1. Nielsen MØ, Rostrup, E, Wulff S, Bak N, Broberg BV, Lublin H, Kapur S, Glenthøj B. Improvement of brain reward abnormalities by antipsychotic monotherapy in schizophrenia. Archives of General Psychiatry 2012. Aug 6:1-10. doi: 10.1001/archgenpsychiatry.2012.847. [Epub ahead of print].
  2. Nielsen MØ, Rostrup E, Wulff S, Bak N, Lublin H, Kapur S, Glenthøj B. Alterations of the Brain Reward System in Antipsychotic Naïve Schizophrenia Patients. Biol Psychiatry 2012; 71:898-905.
  3. Fagerlund B, Pinborg LH, Mortensen EL, Friberg LL, Baaré WF, Gade A, Svarer C, Glenthøj BY. Relationship of frontal D2/3 binding potentials to cognition: a study of antipsychotic-naïve schizophrenia patients. Int J Neuropsychopharmacol 2012 Feb 17:1-4 [Epub ahead of print].
  4. Ebdrup B, Skimminge A, Rasmussen H, Aggernæs B, Oranje B, Lublin H, Baaré W, Glenthøj B. Progressive striatal and hippocampal volume loss in initially antipsychotic naïve first-episode schizophrenia patients treated with quetiapine: relation to dose and symptoms. The Int J Neuropsychopharm. 2011; 14(1):69-82.
  5. Ebdrup BH, Glenthøj BY, Rasmussen H, Aggernaes B, Langkilde AR, Paulson OB, Lublin H, Skimmine A, Baaré W. Hippocampal and Caudate Reductions in Antipsychotic-Naïve First Episode. J Psychiatry Neurosci. 2010; 35:95-104.